A phase I/II trial of AT9283, a selective inhibitor of aurora kinase in children with relapsed or refractory acute leukemia: challenges to run early phase clinical trials for children with leukemia.
| Image |  |
|---|---|
| Description | scientific article published on December 2016 |
| Author/s |
author: Udai Banerji John Grainger Alan V. Boddy Christine J Harrison Andrew S Moore Gareth J Veal |
| Publication date | December 1, 2016 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |